journal article·2020-03Open access

Enzymatic outside-in cross-linking enables single-step microcapsule production for high-throughput three-dimensional cell microaggregate formation

B. van Loo, S.S. Salehi, S. Henke, A. Shamloo, T. Kamperman, M. Karperien, J. Leijten

Abstract

Cell-laden hydrogel microcapsules enable the high-throughput production of cell aggregates, which are relevant for three-dimensional tissue engineering and drug screening applications. However, current microcapsule production strategies are limited by their throughput, multistep protocols, and limited amount of compatible biomaterials. We here present a single-step process for the controlled microfluidic production of single-core microcapsules using enzymatic outside-in cross-linking of tyramine-conjugated polymers. It was hypothesized that a physically, instead of the conventionally explored biochemically, controlled enzymatic cross-linking process would improve the reproducibility, operational window, and throughput of shell formation. Droplets were flown through a silicone delay line, which allowed for highly controlled diffusion of the enzymatic cross-linking initiator. The microcapsules' cross-linking density and shell thickness is strictly depended on the droplet's retention time in the delay line, which is predictably controlled by flow rate. The here presented hydrogel cross-linking method allows for facile and cytocompatible production of cell-laden microcapsules compatible with the formation and biorthogonal isolation of long-term viable cellular spheroids for tissue engineering and drug screening applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Pluripotent Stem Cells Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Digitally tunable physicochemical coding of material composition and topography in continuous microfibres10.1038/nmat3108 ↗
2. Fabrication of microgel particles with complex shape via selective polymerization of aqueous two-phase systems10.1002/smll.201102715 ↗
3. The origins and the future of microfluidics10.1038/nature05058 ↗
4. Generation of monodisperse particles by using microfluidics: control over size, shape, and composition10.1002/anie.200462226 ↗
5. One-step microfluidic generation of pre-hatching embryo-like core-shell microcapsules for miniaturized 3D culture of pluripotent stem cells10.1039/c3lc50678a ↗
6. Cellular capsules as a tool for multicellular spheroid production and for investigating the mechanics of tumor progression in vitro10.1073/pnas.1309482110 ↗
7. Controlled assembly of heterotypic cells in a core–shell scaffold: organ in a droplet10.1039/C6LC00231E ↗
8. Generation of core-shell microcapsules with three-dimensional focusing device for efficient formation of cell spheroid10.1039/C0LC00036A ↗
9. Enzymatically fabricated and degradable microcapsules for production of multicellular spheroids with well-defined diameters of less than 150 microm10.1016/j.biomaterials.2009.07.031 ↗
10. Alginate core-shell beads for simplified three-dimensional tumor spheroid culture and drug screening10.1007/s10544-014-9918-5 ↗
11. Liquefied microcapsules as dual-microcarriers for 3D+3D bottom-up tissue engineering10.1002/adhm.201901221 ↗
12. Life in 3D is never flat: 3D models to optimise drug delivery10.1016/j.jconrel.2015.07.020 ↗
13. Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues
14. Three-dimensional organotypic culture: experimental models of mammalian biology and disease10.1038/nrm3873 ↗
15. Molding cell beads for rapid construction of macroscopic 3D tissue architecture
16. 3D cell culture systems modeling tumor growth determinants in cancer target discovery10.1016/j.addr.2014.03.001 ↗
17. Impact of the spheroid model complexity on drug response10.1016/j.jbiotec.2015.02.029 ↗
18. Healing of a large long-bone defect through serum-free in-vitro priming of human periosteum-derived cells10.1016/j.stemcr.2017.01.005 ↗
19. Bioinspired seeding of biomaterials using three dimensional microtissues induces chondrogenic stem cell differentiation and cartilage formation under growth factor free conditions10.1038/srep36011 ↗
20. Cartilage tissue engineering using pre-aggregated human articular chondrocytes10.22203/eCM.v016a10 ↗
21. Spheroid-based drug screen: considerations and practical approach10.1038/nprot.2008.226 ↗
22. Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells10.1263/jbb.103.389 ↗
23. High throughput generated micro-aggregates of chondrocytes stimulate cartilage formation in vitro and in vivo10.22203/eCM.v023a30 ↗
24. Alginate: properties and biomedical applications10.1016/j.progpolymsci.2011.06.003 ↗
25. Competing two enzymatic reactions realizing one-step preparation of cell-enclosing duplex microcapsules10.1002/btpr.1800 ↗
26. Nanoemulsion-induced enzymatic crosslinking of tyramine-functionalized polymer droplets10.1039/C7TB00686A ↗
27. On-the-fly exchangeable microfluidic nozzles for facile production of various monodisperse micromaterials10.1039/C9LC00054B ↗
28. Centering single cells in microgels via delayed crosslinking supports long-term 3D culture by preventing cell escape
29. Spatiotemporal material functionalization via competitive supramolecular complexation of avidin and biotin analogs10.1038/s41467-019-12390-4 ↗
30. Enzymatic crosslinking of polymer conjugates is superior over ionic or UV crosslinking for the on-chip production of cell-laden microgels10.1002/mabi.201600174 ↗
31. Chondrogenesis in injectable enzymatically crosslinked heparin/dextran hydrogels10.1016/j.jconrel.2011.01.031 ↗
32. Injectable hydrogels by enzymatic co-crosslinking of dextran and hyaluronic acid tyramine conjugates10.1002/masy.201100032 ↗
33. In situ cross-linkable gelatin–poly(ethylene glycol)–tyramine hydrogel via enzyme-mediated reaction for tissue regenerative medicine10.1039/c1jm12527c ↗
34. Injectable chitosan-based hydrogels for cartilage tissue engineering10.1016/j.biomaterials.2009.01.020 ↗
35. Synthesis and characterization of both ionically and enzymatically cross-linkable alginate10.1016/j.actbio.2006.12.002 ↗
36. An injectable, in situ enzymatically gellable, gelatin derivative for drug delivery and tissue engineering10.1016/j.biomaterials.2009.03.030 ↗
37. Covalent incorporation of non-chemically modified gelatin into degradable PVA-tyramine hydrogels10.1016/j.biomaterials.2013.06.005 ↗
38. Enzymatic conjugation of a bioactive peptide into an injectable hyaluronic acid-tyramine hydrogel system to promote the formation of functional vasculature10.1016/j.actbio.2014.02.022 ↗
39. Cytotoxic potency of H2O2 in cell cultures: impact of cell concentration and exposure time10.1016/j.freeradbiomed.2010.07.015 ↗
40. Cytotoxic potency of H2O2 in cell cultures: impact of cell concentration and exposure time10.1016/j.freeradbiomed.2010.07.015 ↗
41. Centering single cells in microgels via delayed crosslinking supports long-term 3D culture by preventing cell escape10.1002/smll.201603711 ↗
42. The effect of injectable gelatin-hydroxyphenylpropionic acid hydrogel matrices on the proliferation, migration, differentiation and oxidative stress resistance of adult neural stem cells10.1016/j.biomaterials.2012.01.037 ↗
43. Modulation of mesenchymal stem cell chondrogenesis in a tunable hyaluronic acid hydrogel microenvironment10.1016/j.biomaterials.2012.01.065 ↗
44. Three-dimensional polymeric systems for cancer cell studies10.1007/s10616-007-9065-4 ↗
45. Gelatine methacrylamide-based hydrogels: an alternative three-dimensional cancer cell culture system10.1016/j.actbio.2014.02.035 ↗